Universal-Beteiligungs- und Servicegesellschaft’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.35M Buy
94,559
+22,761
+32% +$673K 0.01% 1094
2026
Q1
$1.99M Sell
71,798
-8,763
-11% -$225K ﹤0.01% 1248
2025
Q4
$1.75M Buy
80,561
+38,354
+91% +$757K ﹤0.01% 1300
2025
Q3
$639K Buy
42,207
+16,227
+62% +$201K ﹤0.01% 1692
2025
Q2
$293K Buy
25,980
+9,580
+58% +$104K ﹤0.01% 1835
2025
Q1
$165K Hold
16,400
﹤0.01% 1909
2024
Q4
$194K Buy
+16,400
New +$194K ﹤0.01% 998

Other funds holding ROIV

Universal-Beteiligungs- und Servicegesellschaft's ROIV Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Roivant Sciences (ROIV) stake by 32% in Q2 2026, buying an estimated $673K and bringing the position to 94,559 shares worth $3.35M. The position accounts for 0.01% of the portfolio, ranked #1094.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in ROIV in Q4 2024 and has held it in 7 quarters since. 291 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 94,559 shares of Roivant Sciences worth $3.35M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 22,761 Roivant Sciences shares in Q2 2026, an estimated $673K.
  • Roivant Sciences made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1094 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Roivant Sciences in Q4 2024 and has held it in 7 quarters since.
  • 291 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.